176 related items for PubMed ID: 1675705
1. Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. British Association for Paediatric Nephrology.
Lancet; 1991 Jun 29; 337(8757):1555-7. PubMed ID: 1675705
[Abstract] [Full Text] [Related]
2. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
Abeyagunawardena AS, Karunadasa U, Jayaweera H, Thalgahagoda S, Tennakoon S, Abeyagunawardena S.
Pediatr Nephrol; 2017 Aug 29; 32(8):1363-1367. PubMed ID: 28299461
[Abstract] [Full Text] [Related]
3. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
Veltkamp F, Khan DH, Reefman C, Veissi S, van Oers HA, Levtchenko E, Mathôt RAA, Florquin S, van Wijk JAE, Schreuder MF, Haverman L, Bouts AHM.
BMJ Open; 2019 Aug 01; 9(8):e027011. PubMed ID: 31375606
[Abstract] [Full Text] [Related]
4. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA.
Pediatr Nephrol; 2002 May 01; 17(5):355-8. PubMed ID: 12042893
[Abstract] [Full Text] [Related]
5. [Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
Ksiazek J, Kryński J.
Pediatr Pol; 1995 Dec 01; 70(12):1037-42. PubMed ID: 8649943
[Abstract] [Full Text] [Related]
6. Long-term results of two unconventional agents in steroid-dependent nephrotic children.
Donia AF, Ammar HM, El-Agroudy Ael-B, Moustafa Fel-H, Sobh MA.
Pediatr Nephrol; 2005 Oct 01; 20(10):1420-5. PubMed ID: 16047223
[Abstract] [Full Text] [Related]
7. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
Hafeez F, Ahmed TM, Samina U.
J Coll Physicians Surg Pak; 2006 Jan 01; 16(1):35-7. PubMed ID: 16441986
[Abstract] [Full Text] [Related]
8. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A.
Kidney Int; 2019 Jan 01; 95(1):210-218. PubMed ID: 30497684
[Abstract] [Full Text] [Related]
9. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
Ekambaram S, Mahalingam V, Nageswaran P, Udani A, Geminiganesan S, Priyadarshini S.
Indian Pediatr; 2014 May 01; 51(5):371-3. PubMed ID: 24953577
[Abstract] [Full Text] [Related]
10. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
Fu LS, Shien CY, Chi CS.
Nephron Clin Pract; 2004 May 01; 97(4):c137-41. PubMed ID: 15331936
[Abstract] [Full Text] [Related]
11. Effect of levamisole in steroid-dependent nephrotic syndrome.
Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
Iran J Kidney Dis; 2010 Oct 01; 4(4):292-6. PubMed ID: 20852369
[Abstract] [Full Text] [Related]
12. Levamisole in children's idiopathic nephrotic syndrome.
La Manna A, Polito C, Del Gado R, Foglia AC.
Child Nephrol Urol; 2010 Oct 01; 9(4):200-2. PubMed ID: 3255483
[Abstract] [Full Text] [Related]
13. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC, all members of the Levamisole Study Group.
Kidney Int; 2018 Feb 01; 93(2):510-518. PubMed ID: 29054532
[Abstract] [Full Text] [Related]
14. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
Al-Saran K, Mirza K, Al-Ghanam G, Abdelkarim M.
Pediatr Nephrol; 2006 Feb 01; 21(2):201-5. PubMed ID: 16222548
[Abstract] [Full Text] [Related]
15. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome.
Sinha A, Devi KG, Kalra S, Mani K, Hari P, Bagga A.
Kidney Int; 2024 May 01; 105(5):1113-1123. PubMed ID: 38360110
[Abstract] [Full Text] [Related]
16. Levamisole treatment in steroid sensitive nephrotic syndrome.
Alshaya HO, Kari JA.
Saudi Med J; 2002 Sep 01; 23(9):1101-4. PubMed ID: 12370722
[Abstract] [Full Text] [Related]
17. Immunoregulation with levamisole in children with frequently relapsing steroid responsive nephrotic syndrome.
Drachman R, Schlesinger M, Alon U, Mor J, Etzioni A, Shapira H, Ohali M, Drukker A.
Acta Paediatr Scand; 1988 Sep 01; 77(5):721-6. PubMed ID: 3059754
[Abstract] [Full Text] [Related]
18. Levamisole therapy in corticosteroid-dependent nephrotic syndrome.
Bagga A, Sharma A, Srivastava RN.
Pediatr Nephrol; 1997 Aug 01; 11(4):415-7. PubMed ID: 9260236
[Abstract] [Full Text] [Related]
19. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
20. Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children.
Dayal U, Dayal AK, Shastry JC, Raghupathy P.
Nephron; 1994 May 23; 66(4):408-12. PubMed ID: 8015643
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
